BiotechTube
OncoLytika

OncoLytika

London, United Kingdom· Est.
oncolytika.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

OncoLytika Ltd. is a UK-based technical consultancy serving the biotech and pharma industries, specializing in oncology and drug delivery. The company generates revenue through a suite of professional services including technology strategy, due diligence, project management, and securing InnovateUK and EU grant funding for clients. While currently operating as a consultancy, OncoLytika aims to use profits from these services to finance future internal R&D programs focused on novel drug delivery solutions. The small team is led by Managing Director Dr. Mark Eccleston, an experienced biotech entrepreneur.

Oncology

Technology Platform

Consultancy expertise in polymer chemistry, drug delivery, grant writing, and biopharma project management. No proprietary therapeutic platform disclosed.

Opportunities

The growing biotech/pharma sector creates sustained demand for specialized technical consultancy services.
The company's long-term goal of developing internal drug delivery programs represents a potential high-value transition from services to therapeutics, tapping into the critical need for improved oncology treatments.

Risk Factors

Heavy reliance on a consultancy business model makes it sensitive to industry R&D spending cuts.
The planned shift to internal drug development is highly risky, capital-intensive, and outside the team's proven commercial scope.
The company faces scale limitations and key person dependency with a very small core team.

Competitive Landscape

OncoLytika competes in a crowded field of life science consultancies, ranging from individual experts to large firms. Its differentiation lies in its specific technical focus on oncology/drug delivery and its founder's deep network. For its aspirational internal R&D, it would face intense competition from well-funded biotechs and pharma companies with established drug delivery platforms.

More companies in Oncology (General) →More companies in United Kingdom →